News & Updates

Short-term exposure to particulate matter with an aerodynamic diameter ≤1 μm (PM1) appears to contribute to a higher risk of hospital admission for respiratory diseases (RDs), suggests a study.

Repeated administration of low-dose lysergic acid diethylamide (LSD) in an outpatient setting is not necessarily better than placebo at reducing symptoms of attention-deficit/hyperactivity disorder (ADHD), according to the results of a phase IIA trial.

In adults with virologically suppressed HIV-1* infection, switching to a two-drug regimen of doravirine 100 mg and islatravir 0.25 mg (DOR/ISL) was noninferior to continuing bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) or other baseline antiretroviral therapy (bART) regimens in maintaining viral suppression at 48 weeks, according to two phase III trials presented at CROI 2025. 

Among middle-aged women, low creatinine-cystatin C ratio is predictive of reduced fat-free muscle volumes and poorer gait speeds after more than 6 years, as shown in a study.

Individuals with rheumatoid arthritis (RA) are at an increased risk of developing anxiety or both depression and anxiety, according to a study.

Treatment with acoramidis results in a decrease in the composite of all-cause mortality or first cardiovascular-related hospitalization (CVH) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), reports a study.